Leerink Swann Upgrades Genzyme (GENZ) to Outperform; Odds Favor Outperformance

August 21, 2009 8:26 AM EDT Send to a Friend
Leerink Swann upgrades Genzyme (Nasdaq: GENZ) from Market Perform to Outperform

Leerink analyst says, "We are upgrading GENZ to Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login